scholarly journals Indication and outcome of adult liver transplantation for post-Kasai biliary atresia

2021 ◽  
Vol 35 (1) ◽  
pp. S148-S148
Author(s):  
Shin Hwang ◽  
Jung-Man Namgoong ◽  
Chul-Soo Ahn ◽  
Deok-Bog Moon ◽  
Tae-Yong Ha ◽  
...  
2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Naruki Higashidate ◽  
Suguru Fukahori ◽  
Shinji Ishii ◽  
Nobuyuki Saikusa ◽  
Naoki Hashizume ◽  
...  

Abstract Background Apart from Kasai’s procedure, liver transplantation (LTx) has dramatically improved the outcome of children with biliary atresia (BA). However, de novo malignancy has been reported to be one of the major causes of late mortality after LTx among adults. We report a rare case of de novo gastric cancer developing after LTx for BA received during childhood. Case presentation A 21-year-old male patient who had undergone LTx for BA at age 2 years occasionally visited our outpatient clinic due to symptoms of epigastric pain and dysphagia. Endoscopic examination and computed tomography revealed advanced gastric cancer at the gastroesophageal junction with multiple liver metastases. Despite systemic chemotherapy, the disease progressed, resulting in patient’s death 2 years after the diagnosis. Conclusions De novo malignancy in the absence of post-transplant lymphoproliferative disease is rare in pediatric patients who received LTx. To the best of our knowledge, no report has been available on the development of gastric cancer after LTx for BA during childhood. Primary physicians should therefore establish a follow-up plan for patients receiving LTx for BA considering the potential for the development of de novo malignancy, including gastric cancer, despite its rarity.


2021 ◽  
Vol 68 ◽  
pp. 101837
Author(s):  
Yi Luo ◽  
Dong Zhao ◽  
Tao Zhou ◽  
Jianjun Zhu ◽  
Jianjun Zhang ◽  
...  

2004 ◽  
Vol 77 (8) ◽  
pp. 1209-1214 ◽  
Author(s):  
Andreas G. Tzakis ◽  
Panagiotis Tryphonopoulos ◽  
Tomoaki Kato ◽  
Seigo Nishida ◽  
David M. Levi ◽  
...  

2010 ◽  
Vol 89 (5) ◽  
pp. 620-626 ◽  
Author(s):  
Feng Xue ◽  
Jianjun Zhang ◽  
Longzhi Han ◽  
Qigen Li ◽  
Ning Xu ◽  
...  

2008 ◽  
Vol 14 (11) ◽  
pp. 1659-1663 ◽  
Author(s):  
Yukihiro Sanada ◽  
Koichi Mizuta ◽  
Youichi Kawano ◽  
Satoshi Egami ◽  
Makoto Hayashida ◽  
...  

Hepatology ◽  
1999 ◽  
Vol 30 (3) ◽  
pp. 606-611 ◽  
Author(s):  
Christophe Chardot ◽  
Matthieu Carton ◽  
Nathalie Spire-Bendelac ◽  
Christophe Le Pommelet ◽  
Jean-Louis Golmard ◽  
...  

2016 ◽  
Vol 20 (8) ◽  
pp. 1051-1059 ◽  
Author(s):  
Ping Wan ◽  
Dongwei Xu ◽  
Jianjun Zhang ◽  
Qigen Li ◽  
Ming Zhang ◽  
...  

Author(s):  
Pietro Addeo ◽  
Olivier Julliard ◽  
Caroline Schaaf ◽  
Chloe Paul ◽  
François Faitot ◽  
...  

2021 ◽  
Author(s):  
Melanie Le ◽  
Konrad Reinshagen ◽  
Christian Tomuschat

Abstract Purpose: Advances in surgical techniques and perioperative care have improved patients' short-and mid-term postoperative outcomes with Biliary Atresia (BA). However, the long-term results of these patients have not been thoroughly investigated. This systematic review aims to determine the long-term outcomes and the patients' health-related Quality of life (HrQoL) with their native livers or liver transplantation. Methods: A systematic literature-based search for relevant cohorts was performed using Pubmed/Medline, Cochrane Library from its inception to August 2021. Original studies reporting on BA, Hepatoportoenterostomie, portoenterostomy, Kasai, Liver transplantation, Quality of life, or HrQoL were included. Pooled prevalence has been calculated for cholangitis, secondary liver transplantation, or associated malformations using MetaXL (version 5.3). Subgroup analysis on HrQoL followed surgical treatment after BA was calculated by using RevMan (version 5.4).Results: 12 articles were considered for data synthesis. Nine studies compared biliary atresia patients to an age-matched healthy reference group. 4/9 (n = 338) of these studies indicated lower scores for biliary atresia patients; 5/9 (n = 127) stated similar health status. A Forest plot analysis including all studies with total HrQoL showed a tendency of higher scores towards healthy controls (MD -0.79, 95% CI: -6.00-4.41). Comparing patients after Kasai Hepatoportoenterostomy with healthy controls demonstrated favorable outcomes for the control group (MD -3.22, 95% CI: -7.20-0.75) with no statistical significance (p = 0.11). The pooled estimation of the prevalence of cholangitis, secondary liver transplantation and associated malformations are 0.33 (95% CI: 0.06–0.66), 0.59 (95% CI: 0,42–0.75) and 0.13 (95% CI: 0,01–0.33).Conclusion: Biliary atresia patients have an overall high prevalence of progressive liver-related complications and risk of lower HrQoL compared to their healthy peers. Furthermore, those patients who received liver transplantation appear to have the same Quality of life as those living with their native livers. Targeted and evidence-based follow-up procedures and transitional care are essential to meet these patients' long-term care needs. Prospective and multicenter research das focuses on the attributes and predictors of the long-term prognosis of patients with biliary atresia are necessary.


Sign in / Sign up

Export Citation Format

Share Document